Minnesota Court Awards Octane Fitness $1.7 Million in Attorney Fees and Costs

Sep 2, 2015

Reading Time : 1 min

At Icon’s urging, the district court subtracted costs for fees relating to a patent that Octane dropped, expert witness fees over a certain limit, and undocumented computerized legal research costs. But the court rejected Icon’s argument that Octane had “overstaffed this case with partner­level attorneys that were performing tasks [such as document review that are] typically performed by lower billing­rate associates.” Finding that the partners had charged rates commensurate with associate billing rates, the district court concluded that the “case was . . . aggressively litigated by Icon, and Octane properly employed skilled and experienced attorneys to defend itself against Icon’s claims.”

The court also subtracted costs for the appellate and remand proceedings relating to the Section 285 issue, finding that those proceedings were not “exceptional” because “Icon relied on longstanding precedent to argue the case was not exception under the Brooks Furniture standard” and “the Supreme Court broke new ground on the subject by rejecting Brooks Furniture and announcing a new and more flexible standard for determining whether a case is exceptional under [Section] 285.” The court, however, did award fees for Icon’s appeal of the district court’s claim construction order and summary judgment ruling, finding those issues to be “independently exceptional.” Specifically, the court found that “Icon repeated the same exceptionally weak infringement arguments [on appeal] that had been squarely rejected by [the district] court.”

In sum, the district court awarded Octane $1.6 million in fees and $144,697 in costs.

Icon Health & Fitness Inc. v. Octane Fitness LLC, No. 09­319 (D. Minn. Sept. 1, 2015).

Share This Insight

Categories

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.